Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[Parlodel: a new therapeutic possibility in the management of Parkinson disease].

Glaub T, Berecz G, Pintér N, Diószeghy P, Virga A, Mechler F.

Orv Hetil. 1988 Feb 21;129(8):399-402. Hungarian. No abstract available.

PMID:
3279375
2.

[Experience with the use of parlodel in the treatment of Parkinson patients].

Stoliarova LG, Kadykov AS, Shvedkov VV, Pivovarova VM.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1986;86(2):219-22. Russian.

PMID:
3705825
3.

Bromocriptine (ParlodelR) in the treatment of Parkinson's disease.

Molina-Negro P, Grimes JD, Jones MW, Kofman OS, Bouchard S.

Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):503-8. No abstract available.

PMID:
6761765
4.

Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation.

Grøn U, Friis ML, Pakkenberg H.

Acta Neurol Scand. 1980 Feb;61(2):131-6.

PMID:
6994422
5.

Treatment of early morning akinesia with low-dose bromocriptine.

Lindvall B, Olsson JE.

Adv Neurol. 1987;45:543-5. No abstract available.

PMID:
3548264
6.

[Bromocriptine in the treatment of Parkinson's disease].

Sepcić J, Ledić P.

Neurologija. 1982;30(1-4):75-81. Croatian. No abstract available.

PMID:
6765062
7.

Low-dose bromocriptine in the early phases of Parkinson's disease.

Tolosa E, Blesa R, Bayes A, Forcadell F.

Clin Neuropharmacol. 1987 Apr;10(2):168-74.

PMID:
3332610
8.

Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.

LeWitt PA, Gopinathan G, Ward CD, Sanes JN, Dambrosia JM, Durso R, Calne DB.

Neurology. 1982 Jan;32(1):69-72.

PMID:
7033825
9.

Low-dose bromocriptine therapy in severe Parkinson's disease.

Devathasan G, Chong PN, Puvanendran K, Lun KC, Wong PK.

Clin Neuropharmacol. 1984;7(3):231-7.

PMID:
6386152
10.

Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.

Factor SA, Sanchez-Ramos JR, Weiner WJ.

J Neurol Neurosurg Psychiatry. 1988 Apr;51(4):529-33.

11.

Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.

Gawel M, Riopelle R, Libman I, Bouchard S.

Adv Neurol. 1987;45:535-8. No abstract available.

PMID:
3548263
12.

[Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].

Kissel P, Andre JM, Jacquier A.

Nouv Presse Med. 1976 Jan 24;5(4):210. French. No abstract available.

PMID:
1264671
13.

Parkinson's disease: a comparison of mesulergine and bromocriptine.

Burton K, Larsen TA, Robinson RG, Bratty PJ, Martin WR, Schulzer M, Calne DB.

Neurology. 1985 Aug;35(8):1205-8.

PMID:
3895033
14.

Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.

Staal-Schreinemachers AL, Wesseling H, Kamphuis DJ, vd Burg W, Lakke JP.

Neurology. 1986 Feb;36(2):291-3.

PMID:
3511405
15.

Clinical administration of parlodel in low doses.

Lipcsey A, Peres A.

Adv Neurol. 1984;40:557-61. No abstract available.

PMID:
6695636
16.
17.

[Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].

Goulley F, Wolmark Y, Bourdeix I, Chaumet-Riffaud PD.

Therapie. 1993 May-Jun;48(3):233-8. French.

PMID:
7908147
18.

A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.

Libman I, Gawel MJ, Riopelle RJ, Bouchard S.

Can J Neurol Sci. 1987 Nov;14(4):576-80.

PMID:
3319120
19.

[Use of bromocriptine in Parkinson diseases in low doses at a slow rate. 40 patients].

Liaño H, López-Lozano JJ, Ramírez A, Rabes C, Pascual ML.

Arch Neurobiol (Madr). 1984 May-Jun;47(3):143-50. Spanish. No abstract available.

PMID:
6508478
20.

[Bromocriptine (Parlodel) in parkinsonism].

Pakkenberg H.

Ugeskr Laeger. 1978 May 29;140(22):1297. Danish. No abstract available.

PMID:
653876

Supplemental Content

Support Center